Optogenics researchers win a Nobel Prize; Roche bets on Alector brain drug

PartnershipPositive

AI Analysis

Summary

Nobel laureates in optogenetics have laid the foundation for new brain research methods. Roche and CSL executed drug licensing deals while the FDA expanded approved indications for an Eli Lilly medicine.

Outcome Details

Roche and CSL announced drug licensing deals; FDA endorsed broader use of a Lilly medicine

Importance:6/10

Sentiment:

0.60

licensingFDA approvalbrain researchpartnerships

Related Companies

$RHHBY $ALEC $LLY

Read the original article

Published by BioPharma Dive on October 5, 2026 3:09 PM

Read Original